Posts Tagged ‘HIV/AIDS’
October 3, 2022: Lawsuit Over Fake HIV Drugs Expands To 142 Defendants
A lawsuit over fake HIV drugs continues to expand. Syracuse University warned students about fake COVID teats. The DEA seized over ten million fentanyl pills in three months. Congress introduced a bill that would shift COVID-19 funds to fentanyl education and prevention in schools. Counterfeit pills stories in 16 states.
[...]ADAP Advocacy PSA Combat Counterfeit Drugs: The Ad Run Parts 1 and 2
This counterfeit HIV drug outbreak inspired Brandon Mascata of ADAP Advocacy Association (AAA+) to team up with us to produce an educational advertisement for people living with HIV and their loved ones.
[...]June 20, 2022: $230 Million In Diverted HIV Drugs—Again?
A Miami man was charged with selling sketchy HIV medication to U.S. pharmacies; 47 people indicted for fentanyl pill trafficking in four separate investigations; stories about pressed pills in eight states, Ireland and Mexico.
[...]Partnership for Safe Medicines Releases Anti-Counterfeit Public Service Announcement with ADAP Advocacy Association
Washington, D.C. (April 6, 2022) – The Partnership for Safe Medicines has teamed up with the ADAP Advocacy Association (aaa+) to educate people living with HIV on ways they can protect themselves against potential counterfeit medications.
[...]March 16, 2022 Video: Dodgy Drug Websites & HIV
Many criminals are in the fake HIV drug business, and the drugs they sell online are a big threat to the health of HIV patients. Learn more here.
[...]January 24, 2022: 85,000+ bottles of fake HIV medicines
First among the more that two dozen stories in this week’s round up: Gilead Sciences is suing a a network of unauthorized drug suppliers and distributors for selling over 85,000 bottles of counterfeit HIV medicines sold as legitimate Biktarvy and Descovy to U.S. pharmacies.
[...]Fake HIV Medication Reached U.S. Pharmacies—And Patients
A new story in the Wall Street Journal revealed details about the mysterious criminal counterfeiting ring that has been selling fake versions of HIV medications Biktarvy, Symtuza, and Descovy to licensed pharmacies. Read to learn some key things about the crime.
[...]August 9, 2021: Counterfeit HIV treatments reach U.S. pharmacies
Gilead Sciences reports that unauthorized distributors have been selling counterfeit versions of its HIV treatments, Biktarvy and Descovy, to U.S. pharmacies. It’s the second case of counterfeit HIV medicine reaching U.S. pharmacies in the last 12 months.
[...]Counterfeit HIV Drug Alert: Gilead Warns of Fake Versions of Biktarvy and Descovy Sold to U.S. Pharmacies
Gilead has alerted potentially impacted pharmacies to investigate the potential for counterfeit or tampered Gilead medication sold by distributors not authorized by Gilead that may be within their recent supply and to remain vigilant to the potential for this to occur in the future. The authenticity and safety of Gilead-branded medicines can only be secure when obtained directly through Gilead’s authorized distributors.
[...]Counterfeit HIV drug underscores risks of a weaker drug supply chain, advocate warns.
ADAP Advocacy Association CEO Brandon M. Macsata wrote this editorial, which appeared on the AIDS Drug Assistance Program’s website on April 1, 2021.
The Association first warned constituents that counterfeit Symtuza had been distributed to three U.S. pharmacies in December 2020, when Janssen issued an alert.
[...]